Hemozoin

Discovery

Black-brown pigment was observed by Johann Heinrich Meckel in 1847, in the blood and spleen of a person suffering from insanity. However, it was not until 1849 that the presence of this pigment was connected to infection with malaria. Initially, it was thought that this pigment was produced by the body in response to infection, but Charles Louis Alphonse Laveran realized in 1880 that "malaria pigment" is, instead, produced by the parasites, as they multiplied within the red blood cell. The link between pigment and malaria parasites was used by Ronald Ross to identify the stages in the Plasmodium life cycle that occur within the mosquito, since, although these forms of the parasite are different in appearance to the blood stages, they still contain traces of pigment.

Later, in 1891, T. Carbone and W.H. Brown (1911) published papers linking the hemoglobin degradation with pigment production, describing the malaria pigment as a form of hematin and disproving the widely held idea that it is related to melanin. Brown observed that all melanins were bleaching rapidly with potassium permanganate, while with this reagent malarial pigment manifests not the slightest sign of a true bleach reaction. The name "hemozoin" was proposed by Louis Westenra Sambon. In the 1930s several authors identified hemozoin as a pure crystalline form of α-hematin and showed that the substance did not contain proteins within the crystals, but no explanation for the solubility differences between malaria pigment and α-hematin crystals was given.

Formation

During its intraerythrocytic asexual reproduction cycle Plasmodium falciparum consumes up to 80% of the host cell hemoglobin. The digestion of hemoglobin releases monomeric α-hematin (ferriprotoporphyrin IX). This compound is toxic, since it is a pro-oxidant and catalyzes the production of reactive oxygen species. Oxidative stress is believed to be generated during the conversion of heme (ferroprotoporphyrin) to hematin (ferriprotoporphyrin). Free hematin can also bind to and disrupt cell membranes, damaging cell structures and causing the lysis of the host erythrocyte. The unique reactivity of this molecule has been demonstrated in several in vitro and in vivo experimental conditions.

The malaria parasite, therefore, detoxifies the hematin, which it does by biocrystallization—converting it into insoluble and chemically inert β-hematin crystals (called hemozoin). In Plasmodium the food vacuole fills with hemozoin crystals, which are about 100–200 nanometres long and each contain about 80,000 heme molecules.

Several mechanisms have been proposed for the production of hemozoin in Plasmodium, and the area is highly controversial, with membrane lipids,{{cite journal |vauthors=Huy NT, Shima Y, Maeda A, Men TT, Hirayama K, Hirase A, Miyazawa A, Kamei A |title= Phospholipid Membrane-Mediated Hemozoin Formation: The Effects of Physical Properties and Evidence of Membrane Surrounding Hemozoin |journal= PLOS ONE |volume=8 |issue=7 |article-number= e70025|year=2013 |doi=10.1371/journal.pone.0070025|pmid=23894579 |pmc=3720957 The formation of hemozoin in other blood-feeding organisms is not as well-studied as in Plasmodium. However, studies on Schistosoma mansoni have revealed that this parasitic worm produces large amounts of hemozoin during its growth in the human bloodstream. Although the shapes of the crystals are different from those produced by malaria parasites, chemical analysis of the pigment showed that it is made of hemozoin. In a similar manner, the crystals formed in the gut of the kissing bug Rhodnius prolixus during digestion of the blood meal also have a unique shape, but are composed of hemozoin. Hz formation in R. prolixus midgut occurs at physiologically relevant physico-chemical conditions and lipids play an important role in heme biocrystallization. Autocatalytic heme crystallization to Hz is revealed to be an inefficient process and this conversion is further reduced as the Hz concentration increases.

Several other mechanisms have been developed to protect a large variety of hematophagous organisms against the toxic effects of free heme. Mosquitoes digest their blood meals extracellularly and do not produce hemozoin. Heme is retained in the peritrophic matrix, a layer of protein and polysaccharides that covers the midgut and separates gut cells from the blood bolus.

Although β-hematin can be produced in assays spontaneously at low pH, the development of a simple and reliable method to measure the production of hemozoin has been difficult. This is in part due to the continued uncertainty over what molecules are involved in producing hemozoin, and partly from the difficulty in measuring the difference between aggregated or precipitated heme, and genuine hemozoin. Current assays are sensitive and accurate, but require multiple washing steps so are slow and not ideal for high-throughput screening. However, some screens have been performed with these assays.

Structure

β-Hematin crystals are made of dimers of hematin molecules that are, in turn, joined together by hydrogen bonds to form larger structures. In these dimers, an iron-oxygen coordinate bond links the central iron of one hematin to the oxygen of the carboxylate side-chain of the adjacent hematin. These reciprocal iron–oxygen bonds are highly unusual and have not been observed in any other porphyrin dimer. β-Hematin can be either a cyclic dimer or a linear polymer, a polymeric form has never been found in hemozoin, disproving the widely held idea that hemozoin is produced by the enzyme heme-polymerase.

Hemozoin crystals have a distinct triclinic structure and are weakly magnetic. The difference between diamagnetic low-spin oxyhemoglobin and paramagnetic hemozoin can be used for isolation. They also exhibit optical dichroism, meaning they absorb light more strongly along their length than across their width, enabling the automated detection of malaria. Hemozoin is produced in a form that, under the action of an applied magnetic field, gives rise to an induced optical dichroism characteristic of the hemozoin concentration; and precise measurement of this induced dichroism (Magnetic circular dichroism) may be used to determine the level of malarial infection.

Inhibitors

Hemozoin formation is an excellent drug target, since it is essential to malaria parasite survival and absent from the human host. The drug target hematin is host-derived and largely outside the genetic control of the parasite, which makes the development of drug resistance more difficult. Many clinically used drugs are thought to act by inhibiting the formation of hemozoin in the food vacuole. This prevents the detoxification of the heme released in this compartment, and kills the parasite.

The best-understood examples of such hematin biocrystallization inhibitors are quinoline drugs such as chloroquine and mefloquine. These drugs bind to both free heme and hemozoin crystals, and therefore block the addition of new heme units onto the growing crystals. The small, most rapidly growing face is the face to which inhibitors are believed to bind.

Role in pathophysiology

Hemozoin is released into the circulation during reinfection and phagocytosed in vivo and in vitro by host phagocytes and alters important functions in those cells. Most functional alterations were long-term postphagocytic effects, including erythropoiesis inhibition shown in vitro. In contrast, a powerful, short-term stimulation of oxidative burst by human monocytes was also shown to occur during phagocytosis of nHZ. Lipid peroxidation non-enzymatically catalysed by hemozoin iron was described in immune cells. Lipoperoxidation products, as hydroxyeicosatetraenoic acids (HETEs) and 4-hydroxynonenal (4-HNE), are functionally involved in immunomodulation.

References

References

1. (2010). "The legacy of Johann Friedrich Meckel the Elder (1724-1774): a 4-generation dynasty of anatomists". Neurosurgery.
2. Meckel H. (1847). "Ueber schwarzes Pigment in der Milz und dem Blute einer Geisteskranken". Zeitschrift für Psychiatrie.
3. Virchow R. (1849). "Zur pathologischen Physiologie des Bluts". Arch Pathol Anatomie Physiol Klin Med.
4. Sullivan DJ. (December 2002). "Theories on malarial pigment formation and quinoline action". Int J Parasitol.
5. Carbone T. (1891). "Sulla natura chimica del pigmento malarico". G R Accad Med Torino.
6. Brown WH. (1911). "Malarial Pigment (So-Called Melanin): ITS Nature and Mode of Production". J Exp Med.
7. (1934). "Studies of malarial pigment (haemozoin). Part I. Investigation of the action of solvents on haemozoin and the spectroscopical appearances observed in the solutions". Records of the Malaria Survey of India.
8. (December 1996). "Hemoglobin catabolism and iron utilization by malaria parasites". Mol Biochem Parasitol.
9. (2008). "FRET Imaging of Hemoglobin Concentration in Plasmodium falciparum-Infected Red Cells". PLOS ONE.
10. (1983). "Intracellular ferriprotoporphyrin IX is a lytic agent". Blood.
11. (April 1989). "Pathobiology of heme interaction with the erythrocyte membrane". Semin Hematol.
12. (November 1987). "The state of ferriprotoporphyrin IX in malaria pigment". J Biol Chem.
13. (March 2000). "The structure of malaria pigment beta-haematin". Nature.
14. Hempelmann E. (2007). "Hemozoin biocrystallization in Plasmodium falciparum and the antimalarial activity of crystallization inhibitors". Parasitol Research.
15. (December 2005). "Heme oxygenase and heme degradation". Biochem Biophys Res Commun.
16. (June 2008). "Hemozoin: Oil Versus Water". Parasitol Int.
17. (January 1996). "Plasmodium hemozoin formation mediated by histidine-rich proteins". Science.
18. (September 2003). "Hemozoin formation in malaria: a two-step process involving histidine-rich proteins and lipids". Biochem Biophys Res Commun.
19. (April 2008). "HDP—A Novel Heme Detoxification Protein from the Malaria Parasite". PLOS Pathog.
20. (April 2013). "Protein complex directs hemoglobin-to-hemozoin formation in Plasmodium falciparum". Proc Natl Acad Sci U S A.
21. Egan TJ. (February 2008). "Haemozoin formation". Mol Biochem Parasitol.
22. (September 1975). "A comparison of pigment from Schistosoma mansoni and Plasmodium berghei". Ann Trop Med Parasitol.
23. (November 2000). "Haemozoin in Schistosoma mansoni". Mol Biochem Parasitol.
24. (2009). "Interference with Hemozoin Formation Represents an Important Mechanism of Schistosomicidal Action of Antimalarial Quinoline Methanols". PLOS Negl Trop Dis.
25. (2005). "Structural and morphological characterization of hemozoin produced by Schistosoma mansoni and Rhodnius prolixus". FEBS Lett.
26. (2010). "On the physico-chemical and physiological requirements of hemozoin formation promoted by perimicrovillar membranes in Rhodnius prolixus midgut". Insect Biochem Mol Biol.
27. (May 2002). "Aedes aegypti peritrophic matrix and its interaction with heme during blood digestion". Insect Biochem Mol Biol.
28. (March 1998). "A comparison and analysis of several ways to promote haematin (haem) polymerisation and an assessment of its initiation in vitro". Biochem Pharmacol.
29. (February 2005). "Targeting the hemozoin synthesis pathway for new antimalarial drug discovery: technologies for in vitro beta-hematin formation assay". Comb Chem High Throughput Screen.
30. (1949). "Hematin compounds and bile pigments". Interscience, New York.
31. (September 1994). "Analysis of malaria pigment from Plasmodium falciparum". J Pharmacol Toxicol Methods.
32. (1981). "Separation of malaria-infected erythrocytes from whole blood: use of a selective high-gradient magnetic separation technique". Lancet.
33. (2010). "Improved methods for magnetic purification of malaria parasites and haemozoin". Malar J.
34. (February 2019). "Automated malaria detection by depolarization of laser light". Br J Haematol.
35. (2008). "A Magneto-Optic Route toward the In Vivo Diagnosis of Malaria: Preliminary Results and Preclinical Trial Data". Biophys J.
36. (February 2001). "Heme Aggregation inhibitors: antimalarial drugs targeting an essential biomineralization process". Curr Med Chem.
37. (2014). "Malarial hemozoin: From target to tool". Biochim Biophys Acta.
38. (October 1996). "On the molecular mechanism of chloroquine's antimalarial action". Proc Natl Acad Sci USA.
39. (August 2008). "The crystal structure of halofantrine-ferriprotoporphyrin IX and the mechanism of action of arylmethanol antimalarials". J Inorg Biochem.
40. (2008). "Interplay between malaria, crystalline hemozoin formation, and antimalarial drug action and design". Chem Rev.
41. (1997). "Malarial pigment (haemozoin): a very active 'inert' substance". Ann Trop Med Parasitol.
42. (2004). "Hemozoin (malarial pigment) inhibits differentiation and maturation of human monocyte-derived dendritic cells: a peroxisome proliferator-activated receptor-gamma-mediated effect". J Immunol.
43. (2004). "Hemozoin- and 4-hydroxynonenal-mediated inhibition of erythropoiesis. Possible role in malarial dyserythropoiesis and anemia". Haematologica.
44. (2006). "Suppression of erythropoiesis in malarial anemia is associated with hemozoin in vitro and in vivo". Blood.
45. (2010). "Inhibition of erythropoiesis in malaria anemia: role of hemozoin and hemozoin-generated 4-hydroxynonenal.". Blood.
46. (2011). "Host fibrinogen stably bound to hemozoin rapidly activates monocytes via TLR-4 and CD11b/CD18-integrin: a new paradigm of hemozoin action". Blood.
47. (1996). "Increased levels of 4-hydroxynonenal in human monocytes fed with malarial pigment hemozoin. A possible clue for hemozoin toxicity". FEBS Lett..
48. (2015). "Role of the lipoperoxidation product 4-hydroxynonenal in the pathogenesis of severe malaria anemia and malaria immunodepression". Oxid Med Cell Longev.
49. (2021). "Malaria Pigment Hemozoin Impairs GM-CSF Receptor Expression and Function by 4-Hydroxynonenal". Antioxidants.
50. (2014). "Malarial pigment hemozoin impairs chemotactic motility and transendothelial migration of monocytes via 4-hydroxynonenal". Free Radic Biol Med.
51. (2020). "Plasmodium Impairs Antibacterial Innate Immunity to Systemic Infections in Part Through Hemozoin-Bound Bioactive Molecules". Frontiers in Cellular and Infection Microbiology.